Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTBP2 | P56545 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MGLL | Q99685 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8724691 | 1.00 | CTBP2 (0.52) | CTBP2CES1CES2AKR1B1TSHR | |
| SCHEMBL3084456 | 0.75 | CTBP2 (0.75) | CTBP2CES1CES2AKR1B1CA1 | |
| SCHEMBL3084459 | 0.75 | CTBP2 (0.75) | CTBP2CES1CES2AKR1B1CA1 | |
| SCHEMBL3084457 | 0.75 | CTBP2 (0.75) | CTBP2CES1CES2AKR1B1CA1 | |
| SCHEMBL3966062 | 0.75 | CTBP2 (0.56) | CTBP2CES1CES2AKR1B1TSHR | |
| SCHEMBL11090816 | 0.74 | CES1 (0.55) | CTBP2CES1CES2AKR1B1TSHR | |
| SCHEMBL12263048 | 0.74 | CES1 (0.55) | CTBP2CES1CES2AKR1B1TSHR | |
| SCHEMBL6077860 | 0.72 | CES1 (0.52) | CTBP2CES1CES2AKR1B1TSHR | |
| SCHEMBL100774 | 0.71 | HIF1A (0.57) | CTBP2CES1CES2AKR1B1KMT2A | |
| SCHEMBL3658960 | 0.71 | CTBP2 (0.52) | CTBP2CES1CES2AKR1B1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2298761-B1 | HIV INHIBITING PYRIMIDINES DERIVATIVES | JANSSEN PHARMACEUTICA NV (BE) | 2020-03-25 | — | — | EP | disclosed |
| CN-104854236-B9 | Novel UDP-glycosyltransferase derived from ginseng and use thereof | 韩国科学技术院 | 2018-03-13 | — | — | CN | disclosed |
| EP-2900813-B1 | NOVEL UDP-GLYCOSYLTRANSFERASE DERIVED FROM GINSENG AND USE THEREOF | KOREA ADVANCED INST SCI & TECH (KR) | 2018-02-21 | — | — | EP | disclosed |
| US-9670469-B2 | UDP-glycosyltransferase derived from ginseng and use thereof | INTELLIGENT SYNTHETIC BIOLOGY CENTER (KR) | 2017-06-06 | — | — | US | disclosed |
| EP-2900812-B1 | NOVEL UDP-GLYCOSYLTRANSFERASE DERIVED FROM GINSENG AND USE THEREOF | KOREA ADVANCED INST SCI & TECH (KR) | 2017-05-17 | — | — | EP | disclosed |
| US-20150252337-A1 | NOVEL UDP-GLYCOSYLTRANSFERASE DERIVED FROM GINSENG AND USE THEREOF | INTELLIGENT SYNTHETIC BIOLOGY CENTER (KR) | 2015-09-10 | — | — | US | disclosed |
| US-20150240220-A1 | NOVEL UDP-GLYCOSYLTRANSFERASE DERIVED FROM GINSENG AND USE THEREOF | INTELLIGENT SYNTHETIC BIOLOGY CENTER (KR) | 2015-08-27 | — | — | US | disclosed |
| CN-104854236-A | Novel UDP-glycosyltransferase derived from ginseng and use thereof | KOREA ADVANCED INST SCI & TECH | 2015-08-19 | — | — | CN | disclosed |
| CN-104854235-A | Novel udp-glycosyltransferase derived from ginseng and use thereof | KOREA ADVANCED INST SCI & TECH | 2015-08-19 | — | — | CN | disclosed |
| EP-2900813-A1 | NOVEL UDP-GLYCOSYLTRANSFERASE DERIVED FROM GINSENG AND USE THEREOF | Korea Advanced Institute Of Science And Technology (KR) | 2015-08-05 | — | — | EP | disclosed |
| EP-2900812-A1 | NOVEL UDP-GLYCOSYLTRANSFERASE DERIVED FROM GINSENG AND USE THEREOF | Korea Advanced Institute Of Science And Technology (KR) | 2015-08-05 | — | — | EP | disclosed |
| EP-0858511-A1 | PLANTS WITH REDUCED CLUCOSINOLATE CONTENT | PLANT GENETIC SYSTEMS N.V. (BE) | 1998-08-19 | — | — | EP | disclosed |
| WO-1997016559-A1 | PLANTS WITH REDUCED GLUCOSINOLATE CONTENT | PLANT GENETIC SYSTEMS, N.V. (BE) | 1997-05-09 | — | — | WO | disclosed |
| EP-0771878-A1 | Plants with reduced glucosinolate content | PLANT GENETIC SYSTEMS N.V. (BE) | 1997-05-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150252337-A1 | NOVEL UDP-GLYCOSYLTRANSFERASE DERIVED FROM GINSENG AND USE THEREOF | UGGT1, FNTA, UGDH | CTBP2 2789/4885CES1 1494/4885CES2 3072/4885 |
| US-20150240220-A1 | NOVEL UDP-GLYCOSYLTRANSFERASE DERIVED FROM GINSENG AND USE THEREOF | UGGT1, FNTA, UGDH | CTBP2 2789/4885CES1 1494/4885CES2 3072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.